World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
42443
World Ranking
15856
National Ranking
7980

Overview

Andre Goy is affiliated with Hackensack University Medical Center in the United States. Their body of research centers predominantly on medicine, with a focus on oncology, pathology and forensic medicine, genetics, cancer research, and molecular biology.

Their main topics of research include:

  • CAR-T cell therapy research
  • Lymphoma diagnosis and treatment
  • Chronic lymphocytic leukemia research
  • Cancer genomics and diagnostics
  • COVID-19 clinical research studies
  • Acute myeloid leukemia research
  • Viral-associated cancers and disorders

Andre Goy has contributed to multiple recent papers, with some notable examples including:

  • "KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma," 2020, New England Journal of Medicine
  • "Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium," 2020, Journal of Clinical Oncology
  • "Inhibition of Bruton tyrosine kinase in patients with severe COVID-19," 2020, Science Immunology
  • "Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial," 2020, The Lancet Haematology
  • "Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study," 2020, The Lancet Rheumatology

The scientist's frequent co-authors include:

  • Andrew Ip
  • Andrew L. Pecora
  • Brian T. Hill
  • Maher Albitar
  • Javier Muñoz

Andre Goy's work appears regularly in certain academic venues, with the most frequent publication outlets being:

  • Blood
  • Journal of Clinical Oncology
  • Transplantation and Cellular Therapy
  • Clinical Lymphoma Myeloma & Leukemia
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma

    Sattva S. Neelapu;Frederick L. Locke;Nancy L. Bartlett;Lazaros J. Lekakis

  • Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial

    Frederick L Locke;Armin Ghobadi;Caron A Jacobson;David B Miklos

  • Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

    James N. Kochenderfer;Mark E. Dudley;Sadik H. Kassim;Robert P.T. Somerville

  • Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

    Michael L. Wang;Simon Rule;Peter Martin;Andre Goy

  • KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma

    Michael Wang;Javier Munoz;Andre Goy;Frederick L. Locke

  • PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

    Ajay K. Gopal;Ajay K. Gopal;Brad S. Kahl;Sven de Vos;Nina D. Wagner-Johnston

  • Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma

    Wyndham H. Wilson;Ryan M. Young;Roland Schmitz;Yandan Yang

  • Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma

    Richard I. Fisher;Steven H. Bernstein;Brad S. Kahl;Benjamin Djulbegovic

  • High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine

    Jorge E. Romaguera;Luis Fayad;Maria A. Rodriguez;Kristine R. Broglio

  • Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

    Jennifer N. Brudno;Robert P.T. Somerville;Victoria Shi;Jeremy J. Rose

  • Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study

    Owen A. O'Connor;Barbara Pro;Lauren Pinter-Brown;Nancy Bartlett

  • Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

    Andre Goy;Anas Younes;Peter McLaughlin;Barbara Pro

  • Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

    Loretta J. Nastoupil;Michael D. Jain;Lei Feng;Jay Y. Spiegel

  • A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

    Craig H. Moskowitz;Stephen D. Nimer;Andrew D. Zelenetz;Tania Trippett

  • Ibrutinib Combined With Bendamustine and Rituximab Compared With Placebo, Bendamustine, and Rituximab for Previously Treated Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma (HELIOS): A Randomised, Double-Blind, Phase 3 Study

    Asher Chanan-Khan;Paula Cramer;Fatih Demirkan;Graeme Fraser

  • Single-Agent Lenalidomide in Patients With Mantle-Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: Phase II MCL-001 (EMERGE) Study

    Andre Goy;Rajni Sinha;Michael E. Williams;Sevgi Kalayoglu Besisik

  • Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17).

    Jonathan D. Licht;Christine Chomienne;Andre Goy;Alex Chen

  • Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.

    Michael L. Wang;Kristie A. Blum;Peter Martin;Andre Goy

  • Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma

    Craig H. Moskowitz;Joseph R. Bertino;Jill R. Glassman;Eric E. Hedrick

  • Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study

    A. Goy;S. H. Bernstein;B. S. Kahl;B. Djulbegovic

Frequent Co-Authors

David S. Siegel
David S. Siegel Hackensack University Medical Center
Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis
Ranjana H. Advani
Ranjana H. Advani Stanford University
Luis Fayad
Luis Fayad The University of Texas MD Anderson Cancer Center
Michael Wang
Michael Wang Argonne National Laboratory
Pier Luigi Zinzani
Pier Luigi Zinzani University of Bologna
Ian W. Flinn
Ian W. Flinn Sarah Cannon Research Institute
Julie M. Vose
Julie M. Vose University of Nebraska Medical Center
Bruce D. Cheson
Bruce D. Cheson Georgetown University
John P. Leonard
John P. Leonard Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in health care careers but seeking flexible study options, several accredited online degrees and pathways make entering or advancing in the field more accessible. Aspiring registered nurses can take advantage of rn to bsn online programs, which allow current RNs to earn a Bachelor of Science in Nursing, often at affordable tuition rates and with flexible schedules.

Individuals from non-nursing backgrounds can consider direct entry msn programs for non nurses online, which provide a streamlined pathway to a Master of Science in Nursing without requiring prior nursing experience. Additionally, those seeking a quicker route to nursing may explore online adn programs for non nurses—an option that supports entry-level nursing careers and may have more accessible admission requirements.

Not all medical careers require clinical work. For students interested in allied health, medical billing and coding offers strong job prospects. Many institutions offer accredited online programs, and those in need of financial support can investigate financial aid for medical billing and coding to reduce educational costs. These pathways make it easier to start or advance a medical career online.

Best Scientists Citing Andre Goy

Trending Scientists

Recently Published Articles